$SRZN 3 SEC Filings

Filed On	Filing
28 Jan 2026	Form 3: Tcg Crossover Gp II, Llc, 10% owner and 3 others Holds 637,005 shares of Common Stock
13 Nov 2025	Form 3: Maleki Andrew Pedrum, Chief Financial Officer No securities owned
28 Mar 2025	Form 3: Kutzkey Tim, Director Holds 704,332 shares of Common Stock
23 Aug 2023	Form 3: Li Yang, Exec. Vice President, Research Holds 121,524 shares of Common Stock
05 Apr 2023	Form 3: Bjerkholt Eric, Director
16 Aug 2021	Form 3: Column Group Iii GP, Lp, 10% owner and 2 others Holds 4,343,245 shares of Common Stock
16 Aug 2021	Form 3: Kutzkey Tim, Director Holds 4,343,245 shares of Common Stock
16 Aug 2021	Form 3: Parker Craig C, Director
16 Aug 2021	Form 3: Vanhove Geertrui, Chief Medical Officer Holds 22,834 shares of Common Stock
16 Aug 2021	Form 3: Williams Charles O, Chief Financial Officer
16 Aug 2021	Form 3: Woodhouse David J, Director Holds 35,129 shares of Common Stock
16 Aug 2021	Form 3: Rothenberg Mace, Director Holds 35,129 shares of Common Stock
16 Aug 2021	Form 3: Lin Shao-Lee, Director Holds 35,129 shares of Common Stock
16 Aug 2021	Form 3: Haak-Frendscho Mary, Director Holds 35,129 shares of Common Stock
16 Aug 2021	Form 3: Chai Christopher Y, Director Holds 35,129 shares of Common Stock
16 Aug 2021	Form 3: Berkenblit Anna, Director Holds 35,129 shares of Common Stock
16 Aug 2021	Form 3: Yeh Wen-Chen, Chief Scientific Officer Holds 219,560 shares of Common Stock
04 Dec 2020	Form 3: Consonance Capital Management Lp, Director and 2 others No securities owned
18 Nov 2020	Form 3: Consonance Life Sciences, 10% owner
18 Nov 2020	Form 3: Livingston Kevin Harold, Chief Financial Officer

Comments